Inter-Individual Variability in LDL-C Reductions With Inclisiran—Pooled Data From ORION-10 and ORION-11 - 30/07/23
Doi : 10.1016/j.hlc.2023.06.393
P. Psaltis 1, S. Wright 2, F. Raal 3, D. Kallend 4, R. Stoekenbroek 4, W. Koenig 5, L. Leiter 6, U. Landmesser 7, G. Schwartz 8, P. Wijngaard 4, J. Kastelein 9, K. Ray 10
1 Vascular Research Centre, Heart and Vascular Program, Lifelong Health Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia
2 Mayo Clinic, Rochester, NY, USA
3 University of the Witwatersrand, Johannesburg, South Africa
4 The Medicines Company, Parsippany, NJ, USA
5 German Heart Center of Munich, Munich, Germany
6 St Michael’s Hospital, Toronto, ON, Canada
7 Charite Universitatsmedizin Berlin, Berlin, Germany
8 University of Colorado Health, Denver, CO, USA
9 Amsterdam UMC, Amsterdam, Amsterdam
10 Imperial College London, London, UK
397
Il testo completo di questo articolo è disponibile in PDF.Mappa
© 2023
Pubblicato da Elsevier Masson SAS.
Vol 32 - N° S3
P. S291 - luglio 2023 Ritorno al numero
Articolo precedente
- Incidence and Trend of Bleeding Complications and Major Adverse Cardiovascular Events at Discharge, 30 Days and One Year Post Coronary Artery Stenting
- H. Mammatt, J. Vibert, L. Perrett, A. Doost, P. Purnell
- Large Pulmonary Embolism With Paradoxical Embolism to a Coronary Artery Presenting as Inferior ST Elevation Myocardial Infarction, With Concomitant Compression of the Left Main Coronary Artery by a Dilated Main Pulmonary Artery
- M. Fletcher, Z. Zhang, M. Khalil, S. Luke, M. Musameh
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?